Healthcare -
Biotechnology - NASDAQ - US
$ 16.3189
1.36 %
$ 3.86 B
Market Cap
60.44
P/E
Price Target
Average
--31.28%
Revenue Forecast
Estimate
48.17%
EBIT
Estimate
--190.97%
Net Income
Estimate
133.03%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
ADMA Biologics, Inc.
Wall Street analysts predict an average 1-year price target for ADMA of $11.2 , with forecasts ranging from
a
low of
$4 to a high of $18 .
ADMA Lowest Price Target
Wall Street Target
4 USD
-75.49%
ADMA Average Price Target
Wall Street Target
11.2 USD
-31.28%
ADMA Highest Price Target
Wall Street Target
18 USD
10.30%
REVENUE FORECAST
Revenue Forecast Chart ADMA
EBIT FORECAST
EBIT Forecast Chart ADMA
NET INCOME FORECAST
Net Income Chart ADMA